clinical trial · NCT07146854
EndoForce Post Approval Study
Phraxis, Inc.·—·recruiting·n = 150
End Stage Renal Disease (ESRD)
brief summary
The goal of this observational study is to collect long-term safety and performance data for the use of the EndoForce System for connecting a hemodialysis graft to a vein in patients with End Stage Renal Disease. This is not an experimental procedure or an experimental therapy. This means that the study device has been approved by the FDA.
started
Jan 13, 2026
primary completion
Dec 1, 2029
completion
Dec 1, 2029
last updated
Jan 21, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol